SPD503
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for SPD503, covering 2009-10-14 to 2014-05-23. Get the full timeline:
Most recent: Clinical Trial Update: SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP) [Phase 2]